{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:43:43Z","timestamp":1793331823427,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K06835"],"award-info":[{"award-number":["23K06835"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H04923"],"award-info":[{"award-number":["22H04923"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07509"],"award-info":[{"award-number":["22K07509"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K06975"],"award-info":[{"award-number":["23K06975"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K10781"],"award-info":[{"award-number":["25K10781"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H05278"],"award-info":[{"award-number":["21H05278"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02988"],"award-info":[{"award-number":["22H02988"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03350"],"award-info":[{"award-number":["22H03350"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24249"],"award-info":[{"award-number":["23K24249"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07359"],"award-info":[{"award-number":["22K07359"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005694","name":"Hori Sciences and Arts Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22wm0425009"],"award-info":[{"award-number":["22wm0425009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ek0109617"],"award-info":[{"award-number":["24ek0109617"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ek0109492"],"award-info":[{"award-number":["22ek0109492"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25wm0625519"],"award-info":[{"award-number":["25wm0625519"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25ak0101216"],"award-info":[{"award-number":["25ak0101216"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23FC0201"],"award-info":[{"award-number":["23FC0201"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2125"],"award-info":[{"award-number":["JPMJSP2125"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ebiom.2026.106511","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:39:58Z","timestamp":1792539598000},"page":"106511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5170-9169","authenticated-orcid":false,"given":"Kazuki","family":"Obara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Janelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koyo","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Ogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veria","family":"Vacchiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4854-3579","authenticated-orcid":false,"given":"Ryoichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-9524","authenticated-orcid":false,"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-7724","authenticated-orcid":false,"given":"Niklas","family":"Mattsson-Carlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106511_bib1","first-page":"293","article-title":"World federation of neurology research group on motor neuron diseases. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Mot Neuron Disord Off Publ World Fed Neurol Res Group Mot Neuron Dis"},{"key":"10.1016\/j.ebiom.2026.106511_bib2","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS","volume":"131","author":"Shefner","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.ebiom.2026.106511_bib3","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/ene.15874","article-title":"Diagnostic delay in amyotrophic lateral sclerosis","volume":"30","author":"Gwathmey","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib4","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib5","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2026.106511_bib6","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/ene.15813","article-title":"Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"30","author":"Brousse","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105323","article-title":"Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis","volume":"108","author":"Benatar","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2026.106511_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70382","article-title":"Diagnostic and prognostic value of blood and cerebrospinal fluid biomarkers in amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"32","author":"Obara","year":"2025","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106511_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.26462","article-title":"Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis","volume":"92","author":"Cousins","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-57144-7","article-title":"Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis","volume":"16","author":"Abu-Rumeileh","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106511_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70208","article-title":"A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease","volume":"21","author":"Janelidze","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2026.106511_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/acn3.51708","article-title":"Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis","volume":"10","author":"Verde","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp-2018-318868","article-title":"Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase","volume":"90","author":"Oeckl","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2026.106511_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813976","article-title":"Amyloid-beta co-pathology is a major determinant of the elevated plasma GFAP values in amyotrophic lateral sclerosis","volume":"24","author":"Mastrangelo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2026.106511_bib16","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.3390\/ijms21082911","article-title":"A\u03b21-42 and tau as potential biomarkers for diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Lanznaster","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2026.106511_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116756","article-title":"The discriminative capacity of CSF \u03b2-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population","volume":"412","author":"Ye","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebiom.2026.106511_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/brainsci11030302","article-title":"Prognostic role of CSF \u03b2-amyloid 1\u201342\/1\u201340 ratio in patients affected by amyotrophic lateral sclerosis","volume":"11","author":"Colletti","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.ebiom.2026.106511_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16374","article-title":"Association of APOE genotype and cerebrospinal fluid A\u03b2 and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis","volume":"31","author":"Maranzano","year":"2024","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib20","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2026.106511_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-004-0843-1","article-title":"Alzheimer disease pathology in amyotrophic lateral sclerosis","volume":"107","author":"Hamilton","year":"2004","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.ebiom.2026.106511_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40478-016-0301-z","article-title":"Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy","volume":"4","author":"Behrouzi","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ebiom.2026.106511_bib23","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","article-title":"Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform","volume":"31","author":"Palmqvist","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106511_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebiom.2026.106511_bib25","first-page":"346","article-title":"[Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version]","volume":"53","author":"Ohashi","year":"2001","journal-title":"No To Shinkei"},{"key":"10.1016\/j.ebiom.2026.106511_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u2018Mini-mental state\u2019. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.ebiom.2026.106511_bib27","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a frontal assessment battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2026.106511_bib28","doi-asserted-by":"crossref","first-page":"219.e1","DOI":"10.1016\/j.neurobiolaging.2015.11.030","article-title":"Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort","volume":"39","author":"Nakamura","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ebiom.2026.106511_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14508","article-title":"The Alzheimer's association global biomarker standardization consortium (GBSC) plasma phospho-tau round robin study","volume":"21","author":"Ashton","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2026.106511_bib30","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2026.106511_bib31","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s43587-024-00731-y","article-title":"Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability","volume":"4","author":"Therriault","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.ebiom.2026.106511_bib32","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/s41467-024-47971-5","article-title":"Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases","volume":"15","author":"Karlsson","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106511_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","article-title":"Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model","volume":"17","author":"Westeneng","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib34","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1038\/s41467-024-49954-y","article-title":"Temporal stratification of amyotrophic lateral sclerosis patients using disease progression patterns","volume":"15","author":"Amaral D","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106511_bib35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s43588-022-00299-w","article-title":"Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data","volume":"2","author":"Ramamoorthy","year":"2022","journal-title":"Nat Comput Sci"},{"key":"10.1016\/j.ebiom.2026.106511_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100254","article-title":"High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study","volume":"19","author":"Juntas-Morales","year":"2020","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ebiom.2026.106511_bib37","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1111\/ene.16020","article-title":"A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis","volume":"30","author":"Weemering","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1212\/WNL.0000000000002251","article-title":"How common are ALS plateaus and reversals?","volume":"86","author":"Bedlack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2026.106511_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/21678421.2024.2443985","article-title":"Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study","volume":"26","author":"van Eijk","year":"2025","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"10.1016\/j.ebiom.2026.106511_bib40","article-title":"A guide to cross-validation for artificial intelligence in medical imaging","volume":"5","author":"Bradshaw","year":"2023","journal-title":"Radiol Artif Intell"},{"key":"10.1016\/j.ebiom.2026.106511_bib41","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017","journal-title":"arXiv"},{"key":"10.1016\/j.ebiom.2026.106511_bib43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Abe","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib44","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2007.02.006","article-title":"A simple sample size formula for analysis of covariance in randomized clinical trials","volume":"60","author":"Borm","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ebiom.2026.106511_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2026.106511_bib46","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106511_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05767-7","article-title":"CSF and blood levels of Neurofilaments, T-Tau, P-Tau, and Abeta-42 in amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"22","author":"Agah","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.ebiom.2026.106511_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018569","article-title":"Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies","volume":"6","author":"Kobayashi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2026.106511_bib49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1399-0004.1986.tb01901.x","article-title":"A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations","volume":"30","author":"Eto","year":"1986","journal-title":"Clin Genet"},{"key":"10.1016\/j.ebiom.2026.106511_bib50","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2026.106511_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415755","article-title":"TDP-43 proteinopathy and tauopathy: do they have pathomechanistic links?","volume":"23","author":"Riku","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2026.106511_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123112","article-title":"High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS","volume":"463","author":"Ros\u00e9n","year":"2024","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebiom.2026.106511_bib53","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.20170600","article-title":"Short A\u03b2 peptides attenuate A\u03b242 toxicity in vivo","volume":"215","author":"Moore","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2026.106511_bib55","doi-asserted-by":"crossref","first-page":"e958","DOI":"10.1212\/WNL.0000000000013228","article-title":"Association of CSF A\u03b238 levels with risk of Alzheimer disease-related decline","volume":"98","author":"Cullen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2026.106511_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14545","article-title":"Linking higher amyloid beta 1-38 (A\u03b2(1-38)) levels to reduced Alzheimer's disease progression risk","volume":"21","author":"Schneider","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2026.106511_bib57","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1093\/hmg\/dds215","article-title":"Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"21","author":"Bryson","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2026.106511_bib58","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.csbj.2023.01.008","article-title":"The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the 682YENPTY687 motif","volume":"21","author":"Matrone","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.ebiom.2026.106511_bib59","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41582-023-00891-2","article-title":"Biomarkers in amyotrophic lateral sclerosis: current status and future prospects","volume":"19","author":"McMackin","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebiom.2026.106511_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"The BMJ"},{"key":"10.1016\/j.ebiom.2026.106511_bib61","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/genes15040496","article-title":"Neurofilaments in sporadic and familial amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"15","author":"Shahim","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.ebiom.2026.106511_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2021-000143","article-title":"Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis","volume":"3","author":"Alagaratnam","year":"2021","journal-title":"BMJ Neurol Open"},{"key":"10.1016\/j.ebiom.2026.106511_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023600","article-title":"Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis","volume":"6","author":"Steinacker","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ebiom.2026.106511_bib64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s004010051015","article-title":"Immunoreactivity of \u03b2-amyloid precursor protein in amyotrophic lateral sclerosis","volume":"97","author":"Sasaki","year":"1999","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.ebiom.2026.106511_bib65","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/21678421.2024.2309989","article-title":"ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional decline","volume":"25","author":"Hamatani","year":"2024","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"10.1016\/j.ebiom.2026.106511_bib66","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/21678421.2016.1140786","article-title":"The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset","volume":"17","author":"Proudfoot","year":"2016","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"10.1016\/j.ebiom.2026.106511_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.annepidem.2005.09.007","article-title":"Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?","volume":"16","author":"Hern\u00e1ndez","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ebiom.2026.106511_bib68","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jclinepi.2003.09.014","article-title":"Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements","volume":"57","author":"Hern\u00e1ndez","year":"2004","journal-title":"J Clin Epidemiol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:59:08Z","timestamp":1792612748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426003956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"alternative-id":["S2352396426003956"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106511","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106511"}}